Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
After-Hours
In 25 days
PROCEPT BioRobotics
PROCEPT BioRobotics develops and markets innovative robotic medical technology for urology. The company offers the precise Aquaablation therapy with the AquaBeam Robotic System for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH).
All Dates
Earnings history data not available
Company Information
Name
PROCEPT BioRobotics
Country
🇺🇸
More Financial Information